EFFECTS OF DRUGS ON METABOLISM OF THE BRAIN IN VITRO.
D000227:Adenine Nucleotides; D000251:Adenosine Triphosphatases; D000255:Adenosine Triphosphate; D000777:Anesthetics; D001241:Aspirin; D001921:Brain; D002262:Carboxy-Lyases; D000697:Central Nervous System Stimulants; D002746:Chlorpromazine; D004791:Enzyme Inhibitors; D006801:Humans; D066298:In Vitro Techniques; D008660:Metabolism; D008996:Monoamine Oxidase Inhibitors; D010042:Ouabain; D010085:Oxidative Phosphorylation; D004364:Pharmaceutical Preparations; D010600:Pharmacology; D012106:Research; D012110:Reserpine; D012964:Sodium
D000227:Adenine Nucleotides; D000777:Anesthetics; D000697:Central Nervous System Stimulants; D004791:Enzyme Inhibitors; D008996:Monoamine Oxidase Inhibitors; D004364:Pharmaceutical Preparations; D010042:Ouabain; D012110:Reserpine; D000255:Adenosine Triphosphate; D012964:Sodium; D000251:Adenosine Triphosphatases; D002262:Carboxy-Lyases; D001241:Aspirin; D002746:Chlorpromazine
ADENINE NUCLEOTIDES; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; ANALEPTICS; ANESTHETICS; ASPIRIN; BRAIN; CARBOXY-LYASES; CHLORPROMAZINE; DRUGS; ENZYME INHIBITORS; EXPERIMENTAL LAB STUDY; METABOLISM; MONOAMINE OXIDASE INHIBITORS; OUABAIN; OXIDATIVE PHOSPHORYLATION; PHARMACOLOGY; RESERPINE; REVIEW; SODIUM